NEWCARDIO INC

As of September 30, 2011, NEWCARDIO INC carries a market capitalization of 5.20M, placing it among publicly traded companies globally. Its enterprise value stands at 9.09M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2011, NEWCARDIO INC has 32.53M shares outstanding.

These figures are as of September 30, 2011. The price-to-sales ratio is 21.14, and the price-to-book ratio stands at -0.94.

These figures are as of September 30, 2011. The EV/Sales ratio of 38.11 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 9.09M versus a market cap of 5.20M, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2011, NEWCARDIO INC maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -70.50, indicating conservative leverage, while an interest coverage ratio of -22.41 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended September 30, 2011. Return on assets (ROA) is negative at -431.97, reflecting losses generated across the asset base. The company generates approximately 21,689.27 in revenue per employee across its workforce of 11.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended September 30, 2011, NEWCARDIO INC generated 238,582.00 in revenue and converted that into -8.84M in net income, yielding earnings per share of -0.28. EBITDA reached -7.26M, while operating income came in at -7.34M.

As of September 30, 2011, NEWCARDIO INC holds 13,064.00 in cash and equivalents against 3.90M in total debt, resulting in a net debt position of 3.89M. Total book value stands at -5.53M, with working capital of -5.38M providing operational flexibility.

NEWCARDIO INC produced -2.57M in operating cash flow over the twelve months ended September 30, 2011. After subtracting -75,699.00 in capital expenditures, free cash flow totaled -2.65M - equivalent to -0.08 per share.

Over the twelve months ended September 30, 2011, NEWCARDIO INC posted a gross margin of 19.13, reflecting its pricing power and cost economics. The operating margin of -3,076.73 and net profit margin of -3,705.12 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2011. Free cash flow yield is negative at -52.51: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -31.83, meaning NEWCARDIO INC raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of September 30, 2011, NEWCARDIO INC has an Altman Z-Score of -634.07, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.